Referências

1. (2008) Control of Neglected Tropical Diseases (NTD)., , http://www.who.int/neglected_diseases/en/, WHO [cited 2008 Dec 11]. Available at:
2. Hotez, P.J., Molyneux, D.H., Fenwick, A., Control of neglected tropical diseases (2007) N Engl J Med., 357 (10), pp. 1018-1027
3. Medina-Pestana, J.O., Duro-Garcia, V., Strategies for establishing organ transplant programs in developing countries: the Latin America and Caribbean experience (2006) Artif Organs., 30 (7), pp. 498-500
4. (2000) MMWR Recomm Rep., 49 (RR10), pp. 1-7
5. Green, M., Avery, R.K., Guidelines for the prevention and treatment of infectious diseases in the organ transplant recipient (2004) Am J Transplant., 4, pp. 5-166
6. Global tuberculosis control: surveillance, planning, financing: WHO Report 2008
7. Rose, D.N., Benefits of screening for latent Mycobacterium tuberculosis infection (2000) Arch Intern Med., 160 (10), pp. 1513-1521
8. Aguado, J.M., Herrero, J.A., Gavalda, J., Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA (1997) Transplantation., 63 (9), pp. 1278-1286
9. Munoz, P., Rodriguez, C., Bouza, E., Mycobacterium tuberculosis infection in recipients of solid organ transplants (2005) Clin Infect Dis., 40 (4), pp. 581-587
10. Singh, N., Paterson, D.L., Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management (1998) Clin Infect Dis., 27 (5), pp. 1266-1277
11. Sundberg, R., Shapiro, R., Darras, F., A tuberculosis outbreak in a renal transplant program (1991) Transplant. Proc., 23 (6), pp. 3091-3092
12. Koseoglu, F., Emiroglu, R., Karakayali, H., Prevalence of mycobacterial infection in solid organ transplant recipients (2001) Transplant. Proc., 33 (1-2), pp. 1782-1784
13. Rizvi, S.A., Naqvi, S.A., Hussain, Z., Renal transplantation in developing countries (2003) Kidney Int Suppl., (83), pp. S96-S100
14. John, G.T., Shankar, V., Abraham, A.M., Risk factors for posttransplant tuberculosis (2001) Kidney Int., 60 (3), pp. 1148-1153
15. Cordonnier, C., Martino, R., Trabasso, P., Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients (2004) Clin Infect Dis., 38 (9), pp. 1229-1236
16. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America (IDSA), September 1999, and the sections of this statement (2000) Am J Respir Crit Care Med., 161 (4), pp. S221-S247
17. Tavil, B., Gulhan, B., Ozcelik, U., Tuberculin skin test positivity in pediatric allogeneic BMT recipients and donors in Turkey (2007) Pediatr Transplant., 11 (4), pp. 414-418
18. Pai, M., Zwerling, A., Menzies, D., Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update (2008) Ann Intern Med., 149 (3), pp. 177-184
19. (2000) MMWR Recomm Rep., 49 (RR10), pp. 1-7
20. Yeganeh, M., Heidarzade, M., Pourpak, Z., Severe combined immunodeficiency: a cohort of 40 patients (2008) Pediatr Allergy Immunol., 19 (4), pp. 303-306
21. Boggild, A.K., Keystone, J.S., Kain, K.C., Leprosy: a primer for Canadian physicians (2004) CMAJ., 170 (1), pp. 71-78
22. Deps, P.D., Alves, B.L., Gripp, C.G., Contact with armadillos increases the risk of leprosy in Brazil: a case control study (2008) Indian J Dermatol Venereol Leprol., 74 (4), pp. 338-342
23. Clark, B.M., Murray, C.K., Horvath, L.L., Case-control study of armadillo contact and Hansen's disease (2008) Am J Trop Med Hyg., 78 (6), pp. 962-967
24. Britton, W.J., Lockwood, D.N., Leprosy (2004) Lancet., 363 (9416), pp. 1209-1219
25. Abel, L., Sanchez, F.O., Oberti, J., Susceptibility to leprosy is linked to the human NRAMP1 gene (1998) J Infect Dis., 177 (1), pp. 133-145
26. Lockwood, D.N., Suneetha, S., Leprosy: too complex a disease for a simple elimination paradigm (2005) Bull World Health Organ., 83 (3), pp. 230-235
27. (2008) Programs and ProjectsLeprosy Elimination, , http://www.who.int/lep/en/, WHO [cited 11-12-2008]. Available at:
28. Gasink, L.B., Seymour, C., Blumberg, E.A., An uncommon presentation of an uncommon disease: leprosy in a heart transplant recipient (2006) J Heart Lung Transplant., 25 (7), pp. 854-856
29. Launius, B.K., Brown, P.A., Cush, E., A case study in Hansen's disease acquired after heart transplant (2004) Crit Care Nurs Q., 27 (1), pp. 87-91
30. Modi, K., Mancini, M., Joyce, M.P., Lepromatous leprosy in a heart transplant recipient (2003) Am J Transplant., 3 (12), pp. 1600-1603
31. Date, A., John, G.T., Thomas, P.P., Leprosy and renal transplantation (1998) Lepr Rev., 69 (1), pp. 40-45
32. Pieroni, F., Stracieri, A.B., Moraes, D.A., Six cases of leprosy associated with allogeneic hematopoietic SCT (2007) Bone Marrow Transplant., 40 (9), pp. 859-863
33. Bern, C., Montgomery, S.P., Herwaldt, B.L., Evaluation and treatment of Chagas disease in the United States: a systematic review (2007) JAMA., 298 (18), pp. 2171-2181
34. Chagas disease after organ transplantationUnited States (2002) JAMA., 287 (14), pp. 1795-1796
35. (2006) MMWR., 55 (29), pp. 798-800
36. (2007) MMWR., 56 (7), pp. 141-143
37. Dias, J.P., Bastos, C., Araujo, E., Acute Chagas disease outbreak associated with oral transmission (2008) Rev Soc Bras Med Trop., 41 (3), pp. 296-300
38. Schofield, C.J., Jannin, J., Salvatella, R., The future of Chagas disease control (2006) Trends Parasitol., 22 (12), pp. 583-588
39. Dias, J.C., Prata, A., Correia, D., Problems and perspectives for Chagas disease control: in search of a realistic analysis (2008) Rev Soc Bras Med Trop., 41 (2), pp. 193-196
40. Malone, N., Baluja, K.F., Constanzo, J.M., (2003) The Foreign-Born Population: US Census Bureau, , http://www.census.gov/prod/2003pubs/c2kbr-34.pdf, January Available at:
41. Cifras, I.N.E., Extranjeros en Espaa (2008) Boletn Informativo del Instituto Nacional de Estadstica, , http://www.ine.es/revistas/cifraine/cifine_ext0605.pdf, January Available at:
42. Bern, C., Montgomery, S.P., Katz, L., Chagas disease and the US blood supply (2008) Curr Opin Infect Dis., 21 (5), pp. 476-482
43. Schmunis, G.A., Cruz, J.R., Safety of the blood supply in Latin America (2005) Clin Microbiol Rev., 18 (1), pp. 12-29
44. Martin-Davila, P., Fortun, J., Lopez-Velez, R., Transmission of tropical and geographically restricted infections during solidorgan transplantation (2008) Clin Microbiol Rev., 21 (1), pp. 60-96
45. Thambo, S., Passalacqua, W., Van, C.R., Chagas' disease in patients with renal transplantation (1989) Rev Med Chil., 117 (1), pp. 18-22
46. Chocair, P.R., Sabbaga, E., Amato, N., Kidney transplantation: a new way of transmitting Chagas disease (1981) Rev Inst Med Trop Sao Paulo., 23 (6), pp. 280-282
47. Cantarovich, F., Vazquez, M., Garcia, W.D., Special infections in organ transplantation in South America (1992) Transplant. Proc., 24 (5), pp. 1902-1908
48. D'Albuquerque, L.A., Gonzalez, A.M., Filho, H.L., Liver transplantation from deceased donors serologically positive for Chagas disease (2007) Am J Transplant., 7 (3), pp. 680-684
49. Riarte, A., Luna, C., Sabatiello, R., Chagas' disease in patients with kidney transplants: 7 years of experience 1989 (1999) Clin Infect Dis., 29 (3), pp. 561-567
50. Sousa, A.A., Lobo, M.C., Barbosa, R.A., Chagas seropositive donors in kidney transplantation (2004) Transplant. Proc., 36 (4), pp. 868-869
51. Campos, S.V., Strabelli, T.M., Amato, N., Risk factors for Chagas' disease reactivation after heart transplantation (2008) J Heart Lung Transplant., 27 (6), pp. 597-602
52. Altclas, J.D., Barcan, L., Nagel, C., Organ transplantation and Chagas disease (2008) JAMA., 299 (10), pp. 1134-1135
53. Bocchi, E.A., Fiorelli, A., The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi (2001) Ann Thorac Surg., 71 (6), pp. 1833-1838
54. Cruz, I., Morales, M.A., Noguer, I., Leishmania in discarded syringes from intravenous drug users (2002) Lancet., 359 (9312), pp. 1124-1125
55. Le, F.Y., Quaranta, J.F., Aufeuvre, J.P., Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France (1999) J Clin Microbiol., 37 (6), pp. 1953-1957
56. Lessa, M.M., Lessa, H.A., Castro, T.W., Mucosal leishmaniasis: epidemiological and clinical aspects (2007) Rev Bras Otorrinolaringol (Engl Ed)., 73 (6), pp. 843-847
57. Desjeux, P., The increase in risk factors for leishmaniasis worldwide (2001) Trans R Soc Trop Med Hyg., 95 (3), pp. 239-243
58. Desjeux, P., Leishmaniasis: current situation and new perspectives (2004) Comp Immunol Microbiol Infect Dis., 27 (5), pp. 305-318
59. Desjeux, P., Urbanization: an increasing risk factor for leishmaniasis Communicable Diseases Surveillance and Response, 44 (77), p. 365. , http://www.who.int/leishmaniasis/resources/documents/en/wer7744.pdf, -Geneva, Switzerland: WHO 2008 [cited 11-12-2008]. Available at:
60. (2008) Geographical distribution., , Geneva. Switzlerland: WHO
61. Antinori, S., Cascio, A., Parravicini, C., Leishmaniasis among organ transplant recipients (2008) Lancet Infect Dis., 8 (3), pp. 191-199
62. Halkic, N., Ksontini, R., Scholl, B., Recurrent cytomegalovirus disease, visceral leishmaniosis, and Legionella pneumonia after liver transplantation: a case report (2004) Can J Anaesth., 51 (1), pp. 84-87
63. Jokipii, L., Salmela, K., Saha, H., Leishmaniasis diagnosed from bronchoalveolar lavage (1992) Scand J Infect Dis., 24 (5), pp. 677-681
64. Antinori, S., Gianelli, E., Calattini, S., Cutaneous leishmaniasis: an increasing threat for travellers (2005) Clin Microbiol Infect., 11 (5), pp. 343-346
65. Aregawi, M., Cibulskis, R., Otten, M., (2008) The World Malaria ReportWHO Global Malaria Programme
66. Freedman, D.O., Weld, L.H., Kozarsky, P.E., Spectrum of disease and relation to place of exposure among ill returned travelers (2006) N Engl J Med., 354 (2), pp. 119-130
67. Chiche, L., Lesage, A., Duhamel, C., Posttransplant malaria: first case of transmission of Plasmodium falciparum from a white multiorgan donor to four recipients (2003) Transplantation., 75 (1), pp. 166-168
68. Fischer, L., Sterneck, M., Claus, M., Transmission of malaria tertiana by multi-organ donation (1999) Clin Transplant., 13 (6), pp. 491-495
69. Menichetti, F., Bindi, M.L., Tascini, C., Fever, mental impairment, acute anemia, and renal failure in patient undergoing orthotopic liver transplantation: posttransplantation malaria (2006) Liver Transplant., 12 (4), pp. 674-676
70. O'Donnell, J., Goldman, J.M., Wagner, K., Donor-derived Plasmodium vivax infection following volunteer unrelated bone marrow transplantation (1998) Bone Marrow Transplant., 21 (3), pp. 313-314
71. Tran, V.B., Tran, V.B., Lin, K.H., Malaria infection after allogeneic bone marrow transplantation in a child with thalassemia (1997) Bone Marrow Transplant., 19 (12), pp. 1259-1260
72. (2000) MMWR Recomm Rep., 49 (RR10), pp. 1-7
73. Wilder-Smith, A., Schwartz, E., Dengue in travelers (2005) N Engl J Med., 353 (9), pp. 924-932
74. Gibbons, R.V., Vaughn, D.W., Dengue: an escalating problem (2002) BMJ., 324 (7353), pp. 1563-1566
75. (2008) Situacin epideliolgica de dengue en Isla de Pascua, , http://epi.minsal.cl/epi/html/bolets/reportes/Dengue/Informedengue.pdf, Ministerio de Salud de Chile [cited 2008 Dec 11]
76. Available at:
77. Hotez, P.J., Bottazzi, M.E., Franco-Paredes, C., The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination (2008) PLoS Negl Trop Dis., 2 (9), p. e300
78. Figueiredo, L.T., Cavalcante, S.M., Simoes, M.C., Dengue serologic survey of school children in Rio de Janeiro, Brazil, in 1986 (1990) Bull Pan Am Health Organ., 24 (2), pp. 217-225
79. Torres, J.R., Castro, J., The health and economic impact of dengue in Latin America (2007) Cad Saude Publica., 23, pp. S23-S31
80. Guzman, M.G., Kouri, G., Dengue: an update (2002) Lancet Infect Dis., 2 (1), pp. 33-42
81. Beatty, M.E., Clark, G.G., Dengue fever (2008) CDC Health Information for International TravelersYellow book, , http://wwwn.cdc.gov/travel/yellowBookCh4-DengueFever.aspx, [cited 2008 Dec 11]
82. Available at:
83. Azevedo, L.S., Carvalho, D.B., Matuck, T., Dengue in renal transplant patients: a retrospective analysis (2007) Transplantation., 84 (6), pp. 792-794
84. Chacko, B., John, G.T., Jacob, C.K., Dengue shock syndrome in a renal transplant recipient (2004) Transplantation., 77 (4), pp. 634-635
85. Garcia, J.H., Rocha, T.D., Viana, C.F., Dengue shock syndrome in a liver transplant recipient (2006) Transplantation., 82 (6), pp. 850-851
86. Park, S.B., Ryu, S.Y., Jin, K.B., Acute colitis associated with dengue fever in a renal transplant recipient (2008) Transplant. Proc., 40 (7), pp. 2431-2432
87. Renaud, C.J., Manjit, K., Pary, S., Dengue has a benign presentation in renal transplant patients: a case series (2007) Nephrology (Carlton)., 12 (3), pp. 305-307
88. Rigau-Perez, J.G., Vorndam, A.V., Clark, G.G., The dengue and dengue hemorrhagic fever epidemic in Puerto Rico, 1994 (2001) Am J Trop Med Hyg., 64 (1-2), pp. 67-74
89. Tan, F.L., Loh, D.L., Prabhakaran, K., Dengue haemorrhagic fever after living donor renal transplantation (2005) Nephrol Dial Transplant., 20 (2), pp. 447-448
90. Linnen, J.M., Vinelli, E., Sabino, E.C., Dengue viremia in blood donors from Honduras, Brazil, and Australia (2008) Transfusion., 48 (7), pp. 1355-1362
91. Mohammed, H., Linnen, J.M., Munoz-Jordan, J.L., Dengue virus in blood donations, Puerto Rico (2008) Transfusion., 48 (7), pp. 1348-1354
92. Barrett, A.D., Higgs, S., Yellow fever: a disease that has yet to be conquered (2007) Annu Rev Entomol., 52, pp. 209-229
93. Vasconcelos, P.F., Yellow fever (2003) Rev Soc Bras Med Trop., 36 (2), pp. 275-293
94. Cetron, M.S., Marfin, A.A., Julian, K.G., Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) (2002) MMWR Recomm Rep., 51 (RR-17), pp. 1-11
95. Monath, T.P., Cetron, M.S., Prevention of yellow fever in persons traveling to the tropics (2002) Clin Infect Dis., 34 (10), pp. 1369-1378
96. (2008) Situao da Febre Amarela Silvestre no pas 2007-Boletim Epidemiolgico CVS, , www.portal.saude.gov.br/portal/arquivos/pdf/boletim_svs_febre_amarela_11_06.pdf, November 6 [cited 2008 Dec 11]. Available at:
97. Duchini, A., Goss, J.A., Karpen, S., Vaccinations for adult solidorgan transplant recipients: current recommendations and protocols (2003) Clin Microbiol Rev., 16 (3), pp. 357-364
98. Dykewicz, C.A., Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients (2001) Clin Infect Dis., 33 (2), pp. 139-144
99. Gowda, R., Cartwright, K., Bremner, J.A., Yellow fever vaccine: a successful vaccination of an immunocompromised patient (2004) Eur J Haematol., 72 (4), pp. 299-301
100. Ljungman, P., Vaccination after hematopoietic stem cell transplantation. (2008) Vaccine., pp. 1403-1416. , 5th ed. PA: Saunders Elsevier, Stanley A. Plotkin, Walter A. Orenstein, Paul A. Offit eds
101. Rio, B., Marjanovic, Z., Lvy, V., Vaccination of yellow fever after bone marrow transplantation (1996) Bone Marrow Transplant., 17, p. 95
102. Manual dos Centros de Referncia para Imunobiolgicos Especiais (2006) Ministrio da Sade, , www.sbinfecto.org.br/anexos/MS_PNI_manual%20CRIE%202006.pdf, December 12 [cited 2008 Dec 11]. Available at:
103. Reinhardt, B., Jaspert, R., Niedrig, M., Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection (1998) J Med Virol., 56 (2), pp. 159-167
104. Rima, B.K., Duprex, W.P., Morbilliviruses and human disease (2006) J Pathol., 208 (2), pp. 199-214
105. Gay, N.J., The theory of measles elimination: implications for the design of elimination strategies (2004) J Infect Dis., 189, pp. S27-S35
106. (2007) Measles, , www.who.int/mediacentre/factsheets/fs286/en/, WHO [cited 2008 Dec 11]
107. Fact sheet no. Available at:
108. Machado, C.M., Goncalves, F.B., Pannuti, C.S., Measles in bone marrow transplant recipients during an outbreak in Sao Paulo, Brazil (2002) Blood., 199 (1), pp. 83-87
109. Warmington, L., Lee, B.E., Robinson, J.L., Loss of antibodies to measles and varicella following solid organ transplantation in children (2005) Pediatr Transplant., 9 (3), pp. 311-314
110. Ljungman, P., Fridell, E., Lonnqvist, B., Efficacy and safety of vaccination of marrow transplant recipients with a live-attenuated measles, mumps, and rubella vaccine (1989) J Infect Dis., 159 (4), pp. 610-615
111. Lee, D.G., Yoo, J.H., Choi, J.H., A fatal case of measles pneumonia complicating an adult recipient of hemopoietic stem cell transplantation during the nationwide epidemic in Korea (2006) Int J Infect Dis., 10 (5), pp. 410-411
112. Yoo, J.H., Lee, D.G., Choi, S.M., Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea (2004) Bone Marrow Transplant., 34 (6), pp. 497-504
113. Agamanolis, D.P., Tan, J.S., Parker, D.L., Immunosuppressive measles encephalitis in a patient with a renal transplant (1979) Arch Neurol., 36 (11), pp. 686-690
114. Kalman, S., Bakkaloglu, S.A., Ozkaya, O., Measles: a rare communicable disease in a child with renal transplantation (2002) Pediatr Transplant., 6 (5), pp. 432-434
115. Klapper, P.E., Cleator, G.M., Clarke, M.C., Measles immunisation (1991) Arch Dis Child., 66 (3), p. 369
116. Turner, A., Jeyaratnam, D., Haworth, F., Measles-associated encephalopathy in children with renal transplants (2006) Am J Transplant., 6 (6), pp. 1459-1465
117. Machado, C.M., deSouza, V.A., Early measles vaccination in bone marrow transplant recipients (2005) Bone Marrow Transplant., 35 (8), pp. 787-791
118. Luthy, K.E., Tiedeman, M.E., Beckstrand, R.L., Safety of livevirus vaccines for children with immune deficiency (2006) J Am Acad Nurse Pract., 18 (10), pp. 494-503
119. Kano, H., Mizuta, K., Sakakihara, Y., Efficacy and safety of immunization for pre- and post-liver transplant children (2002) Transplantation., 74 (4), pp. 543-550
120. Rand, E.B., McCarthy, C.A., Whitington, P.F., Measles vaccination after orthotopic liver transplantation (1993) J Pediatr., 123 (1), pp. 87-89
121. Khan, S., Erlichman, J., Rand, E.B., Live virus immunization after orthotopic liver transplantation (2006) Pediatr Transplant., 10 (1), pp. 78-82
122. Measles once again endemic in the United Kingdom (2008) Eurosurveill, 13 (1)
123. (2008) MMWR., 57 (33), pp. 893-896
124. Rupprecht, C.E., Hanlon, C.A., Hemachudha, T., Rabies re-examined (2002) Lancet Infect Dis., 2 (6), pp. 327-343
125. De, S.G., Dallaire, F., Cote, M., Bat rabies in the United States and Canada from 1950 through 2007: human cases with and without bat contact (2008) Clin Infect Dis., 46 (9), pp. 1329-1337
126. Manning, S.E., Rupprecht, C.E., Fishbein, D., Human rabies preventionUnited States, 2008: recommendations of the Advisory Committee on Immunization Practices (2008) MMWR Recomm Rep., 57 (RR-3), pp. 1-28
127. Bronnert, J., Wilde, H., Tepsumethanon, V., Organ transplantations and rabies transmission (2007) J Travel Med., 14 (3), pp. 177-180
128. (2008) Facts and figures. Global estimates and trends, , http://www.iom.int/jahia/Jahia/facts-and-figures/global-estimates-and-trends, International Organization for Migration [cited 2008 Dec 11]
129. Available at: